About TFF

scientist in lab - About TFF hero

At TFF Pharmaceuticals, we believe striving for excellence leads to extraordinary solutions. Our novel drug delivery technology, Thin Film Freezing, is designed to make treatments available to patients as safely and efficiently as possible. Maintaining the highest standards of performance, professionalism, ethics, and integrity is vital to our efforts to transform the drug delivery and development landscape.

Our strategic approach includes both internal clinical development programs and out-licensing activities in which we provide formulation and process solutions to improve stability and delivery properties of current and new treatments.

Our highly experienced and motivated team is committed to collaborating widely, fulfilling our vision of unlocking the potential of a diverse array of therapies across many disease areas. Our guiding mission is to enhance health and to improve the lives of people around the world.

green lines

Management Team

Zamaneh Mikhak, M.D.
Chief Medical Officer
Kirk Coleman
Chief Financial Officer
Dale Christensen
Vice President of Preclinical Research and Early Development
John J. Koleng, Ph.D., R.Ph.
Vice President of Product Development and Manufacturing
G.J. Davenport
Vice President of Government and Strategic Initiatives
John Choi
Vice President of Regulatory Affairs
Anthony Hickey, Ph.D.
Senior Research and Development Advisor and Chairman of the Scientific Advisory Board
Chris Cano
Business Development Advisor
Robert O. (Bill) Williams III, Ph.D.
Technology Inventor/Special Advisor

Board of Directors

Scientific Advisory Board

circles background element


We collaborate with many prominent drug development companies as well as academic institutions and government agencies to improve efficacy, safety, and delivery of both approved therapeutics and those in development.

Corporate Fact Sheet

red lines -design element


If you’re interested in joining our team to advance innovative therapies, we encourage you to get in touch.